Results
​​Twenty-nine patients had a supervised, automated Dora call as part of their care following informed consent. Age ranged from 22 - 83 years, (mean 47 years), with 19 female and 10 male patients. 100% (n=29) of the calls were successfully completed, and 100% (n=29) of the symptoms were satisfactorily labelled by the supervising clinician from Dora’s automated conversation. Dora was able to independently capture and label 95% of all the symptoms (Range 83%-100%). Of the 406 symptom labels, agreement levels between Dora and the clinical supervisor were on average 89% (range 79-100%) (Figure 1). 66% (n=19) were classified as ‘high’ risk of having HNC (>7.1%), with 34% (n=10) classified as low risk of having HNC (<7.0%). None of the patients were ultimately diagnosed with HNC (confirmed at 1 year).
Patient acceptability was high, net promoter scores ranged from 4 to 10, with a median NPS of 8 out of 10, and a calculated NPS of 56% (Figure 2).